0ND5 vs 2CUREX: Side-by-Side Comparison
Compare H Lundbeck A/S (0ND5) and 2cureX AB (2CUREX) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0ND5 | 2CUREX |
|---|---|---|
| Company | H Lundbeck A/S | 2cureX AB |
| Country / Exchange | Denmark · LSE | Denmark · ST |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
| Market cap | — | SEK 46.39M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | DKK 24.63B | SEK 0 |
| Revenue growth YoY | +11.9% | — |
| Net income | DKK 3.19B | SEK -4.55M |
| Gross margin | 82.7% | — |
| Diluted EPS | 3.22 | -0.18 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.